Pre-operative glycaemic control and long-term survival in diabetic patients after coronary artery bypass grafting

Salil Deo1, Varun Sundaram2,3, Muhammad Adil Sheikh4

  • 1Surgical Services, Louis Stokes Cleveland VA Medical Center, VA Northeast Ohio Healthcare System, Cleveland, OH, USA.

Insights

Elevated pre-operative glycated haemoglobin (HbA1c) levels above 8% in patients undergoing coronary artery bypass grafting (CABG) are linked to higher mortality and adverse cardiac events. Managing HbA1c is crucial for long-term outcomes after CABG surgery.

Area of Science:

  • Cardiology
  • Diabetology
  • Surgical Outcomes

Background:

  • Diabetes mellitus is a significant comorbidity in patients undergoing coronary artery bypass grafting (CABG).
  • Pre-operative glycemic control, measured by glycated haemoglobin (HbA1c), may impact long-term outcomes after CABG.

Purpose of the Study:

  • To evaluate the association between pre-operative glycated haemoglobin (HbA1c) levels and long-term outcomes in veterans undergoing isolated coronary artery bypass grafting (CABG).

Main Methods:

  • Analysis of Veteran Affairs data from 2006-2018 for patients with diabetes mellitus undergoing isolated CABG.
  • Patients were stratified into four groups based on pre-operative HbA1c levels (<6.5%, 6.5-8%, 8-10%, >10%).
  • Multivariable Cox proportional hazards models and competing risks models were used to assess mortality, myocardial infarction (MI), and repeat revascularization.

Main Results:

  • A total of 16,190 patients were analyzed, with a median follow-up of 5.8 years.
  • Mortality rates increased with HbA1c levels >8%, particularly above 9%.
  • Pre-operative HbA1c levels of 8-10% and >10% were associated with increased risk of MI (HR 1.24, 1.39) and reintervention (HR 1.20, 1.24) compared to HbA1c <8%.

Conclusions:

  • Pre-operative HbA1c levels exceeding 8% are associated with an increased risk of mortality and adverse cardiac events in patients undergoing CABG.
  • Optimizing glycemic control before CABG surgery may improve long-term patient outcomes.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
90
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
95
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
91
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
663
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K